Patent · US Active

Polymeric synthetic antidote

US9616089B2 · kind B2 · utility

0Cited by

0References

18Claims

0Family size

Assignee

UNIVERSITE DE LIEGE · BE

Inventors

Christian GRANDFILS · Liège, BE
Lucas Flebus · Soheit-Tinlot, BE
Chantal SEVRIN · Liège, BE

Key dates

Filing date	Aug 8, 2014
Grant date	Apr 11, 2017
Priority date	—
Expiry date	Aug 8, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC08F120/34
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A polymer of formula (I) where X1 and X2 respectively represent the alpha and omega end groups of the polymer; R1 represents a hydrogen atom or a straight or branched chain alkyl group; R2 represents a straight or branched chain alkyl group which is substituted by a group which may have a positive charge at physiological pH; and n represents the number of repetitive units of the polymer, or a copolymer thereof; for use as a medicament and for treatment of a heparin overdose wherein the polymer of formula (I) has been found to have a selectivity and affinity for heparin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.